Innate Pharma
IPHA
#8681
Rank
โ‚ฌ0.14 B
Marketcap
1,62ย โ‚ฌ
Share price
-1.05%
Change (1 day)
-9.84%
Change (1 year)

Revenue for Innate Pharma (IPHA)

Revenue in 2024: โ‚ฌ12.62 Million

According to Innate Pharma 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ11.26 Million. In 2024 the company made a revenue of โ‚ฌ12.62 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ51.9 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innate Pharma from 2005 to 2024

Annual revenue

Year Revenue Change
2024โ‚ฌ12.62 M-75.68%
2023โ‚ฌ51.9 M4.68%
2022โ‚ฌ49.58 M309.41%
2021โ‚ฌ12.11 M-78.43%
2020โ‚ฌ56.15 M-18.15%
2019โ‚ฌ68.6 M-14.12%
2018โ‚ฌ79.89 M144.83%
2017โ‚ฌ32.63 M-41.9%
2016โ‚ฌ56.16 M213.64%
2015โ‚ฌ17.9 M1874.2%
2014โ‚ฌ0.9 M-92.73%
2013โ‚ฌ12.46 M20.16%
2012โ‚ฌ10.37 M39.21%
2011โ‚ฌ7.45 M72.55%
2010โ‚ฌ4.32 M-44.01%
2009โ‚ฌ7.71 M-40.3%
2008โ‚ฌ12.92 M-9.56%
2007โ‚ฌ14.29 M68.57%
2006โ‚ฌ8.47 M246.85%
2005โ‚ฌ2.44 M